Skip to main content
. 2017 Jan 1;11(1):EC17–EC23. doi: 10.7860/JCDR/2017/22671.9291

[Table/Fig-6]:

Relationship between immunohistochemical expression of ALDH1 and clinicopathologic factors in the studied colorectal carcinoma.

Variables Expression of ALDH1 Test of significance p-value
Positive Negative
Age
Mean±SD 50.51±12.41 62.17.±13.7 u=96.5 0.003**
≤ 45 12(85.7%) 2(14.3%) FE=1.11 0.45
> 45 25(71.4%) 10(28.6%)
Sex
Male 15(78.9%) 4(21.1%) FE=1.98 0.74
Female 22(73.3%) 8(26.7%)
Size
Mean±SD 6.43±3.44 4.75±1.73 u=171.5 0.24
≤ 5 18(66.7%) 9(33.3%) χ2=2.54 0.11
> 5 19(86.4%) 3(13.6%)
Site
Left 15(62.5%) 9(37.5%) χ2=4.31 0.03*
Right 22(88%) 3(12%)
Gross
Fungating 23(88.5%) 3(11.5%) χ2=5.09 0.08
Ulcerating 12(60%) 8(40%)
Annular 2(66.7%) 1(33.3%)
Type
Adenocarcinoma 29(72.5%) 11(27.5%) FE=1.07 0.42
Mucoid carcinoma 8(88.9%) 1(11.1%)
Grade
I 1(100%) 0(0%) χ2=1.49 0.48
II 28(71.8%) 11(28.2%)
III 8(88.9%) 1(11.1%)
Vascular invasion
Present 6(85.7%) 1(14.3%) FE=0.46 0.67
Absent 31(73.8%) 11(26.2%)
Necrosis
Present 16(66.7%) 8(33.3%) χ2=1.99 0.19
Absent 21(84%) 4(16%)
Perineural invasion
Present 6(85.7%) 1(14.3%) FE=0.46 0.67
Absent 31(73.8%) 11(26.2%)
Lymph node invasion
Present 19(90.5%) 2(9.5%) χ2=4.45 0.03*
Absent 18(64.3%) 10(35.7%)
N0 18(64.3%) 10(35.7%) χ2=4.51 0.10
N1 12(92.3%) 1(7.7%)
N2 7(87.5%) 1(12.5%)
Stage
T1 1(100%) 0(0%) χ2=1.56 0.67
T2 7(63.6%) 4(36.4%)
T3 19(76%) 6(24%)
T4 10(83.3%) 2(16.7%)
Modified Dukes stage
A 1(100%) 0(0%) χ2=3.54 0.47
B1 3(75%) 1(25%)
B2 14(63.6%) 8(36.4%)
C1 9(90%) 1(10%)
C2 10(83.3%) 2(16.7%)
Mitotic count
Mean±SD 8.68±4.56 8.1±4.23 U=201.5 0.63
Apoptotic
Mean±SD 3.29±2.61 4.05.±3.54. U=186.5 0.41

SD: standerd deviation FE: Fisher’s Exact χ2=Chi-Squares U= Mann-Whitney *=significance **= highly significance